Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD276 overexpression
i
Other names:
CD276, CD276 Molecule, CD276 Antigen, B7 Homolog 3, B7-H3, B7RP-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
80381
Related biomarkers:
Expression
Others
‹
›
Associations
(12)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Safety Study of MGA271 in Refractory Cancer (NCT01391143)
Phase 1
MacroGenics
MacroGenics
Completed
Phase 1
MacroGenics
Completed
Last update posted :
02/08/2022
Initiation :
07/01/2011
Primary completion :
04/18/2019
Completion :
04/18/2019
CD276
|
CD276 overexpression
|
enoblituzumab (MGA271)
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.